These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Opioid plasma concentration during switching from morphine to methadone: preliminary data. Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541 [TBL] [Abstract][Full Text] [Related]
4. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694 [TBL] [Abstract][Full Text] [Related]
5. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population. Tse DM; Sham MM; Ng DK; Ma HM Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853 [TBL] [Abstract][Full Text] [Related]
6. The role of methadone in opioid rotation-a Polish experience. Leppert W Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743 [TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain. Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345 [TBL] [Abstract][Full Text] [Related]
9. Methadone titration in opioid-resistant cancer pain. Scholes CF; Gonty N; Trotman IF Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950 [TBL] [Abstract][Full Text] [Related]
10. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial. Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131 [TBL] [Abstract][Full Text] [Related]
11. The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study. Mercadante S; Ferrera P; Arcuri E Support Care Cancer; 2011 Mar; 19(3):435-8. PubMed ID: 20882391 [TBL] [Abstract][Full Text] [Related]
12. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363 [TBL] [Abstract][Full Text] [Related]
13. Treatment of pain in chronic bowel subobstruction with self-administration of methadone. Mercadante S; Sapio M; Serretta R Support Care Cancer; 1997 Jul; 5(4):327-9. PubMed ID: 9257431 [TBL] [Abstract][Full Text] [Related]
14. Switching from methadone to a different opioid: what is the equianalgesic dose ratio? Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450 [TBL] [Abstract][Full Text] [Related]
15. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307 [TBL] [Abstract][Full Text] [Related]
16. Intermittent subcutaneous methadone administration in the management of cancer pain. Centeno C; Vara F J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. De Conno F; Groff L; Brunelli C; Zecca E; Ventafridda V; Ripamonti C J Clin Oncol; 1996 Oct; 14(10):2836-42. PubMed ID: 8874346 [TBL] [Abstract][Full Text] [Related]
18. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176 [TBL] [Abstract][Full Text] [Related]
19. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. Mercadante S; Casuccio A; Agnello A; Serretta R; Calderone L; Barresi L J Clin Oncol; 1998 Nov; 16(11):3656-61. PubMed ID: 9817288 [TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]